Ardelyx Inc (ARDX)
8.72
+1.93
(+28.42%)
USD |
NASDAQ |
May 03, 16:00
8.70
-0.02
(-0.23%)
After-Hours: 20:00
Ardelyx Total Assets (Quarterly): 297.58M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 297.58M |
| September 30, 2023 | 289.38M |
| June 30, 2023 | 211.20M |
| March 31, 2023 | 217.02M |
| December 31, 2022 | 190.07M |
| September 30, 2022 | 144.67M |
| June 30, 2022 | 131.61M |
| March 31, 2022 | 129.41M |
| December 31, 2021 | 149.91M |
| September 30, 2021 | 170.85M |
| June 30, 2021 | 204.98M |
| March 31, 2021 | 210.29M |
| December 31, 2020 | 201.56M |
| September 30, 2020 | 198.56M |
| June 30, 2020 | 217.34M |
| March 31, 2020 | 235.32M |
| December 31, 2019 | 259.78M |
| September 30, 2019 | 119.41M |
| June 30, 2019 | 137.98M |
| March 31, 2019 | 166.14M |
| December 31, 2018 | 183.33M |
| Date | Value |
|---|---|
| September 30, 2018 | 206.67M |
| June 30, 2018 | 228.54M |
| March 31, 2018 | 142.84M |
| December 31, 2017 | 157.90M |
| September 30, 2017 | 143.10M |
| June 30, 2017 | 164.12M |
| March 31, 2017 | 187.76M |
| December 31, 2016 | 213.13M |
| September 30, 2016 | 241.32M |
| June 30, 2016 | 155.38M |
| March 31, 2016 | 180.50M |
| December 31, 2015 | 116.95M |
| September 30, 2015 | 138.07M |
| June 30, 2015 | 148.19M |
| March 31, 2015 | 105.40M |
| December 31, 2014 | 113.41M |
| September 30, 2014 | 117.73M |
| June 30, 2014 | 123.48M |
| March 31, 2014 | 40.55M |
| December 31, 2013 | 42.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
119.41M
Minimum
Sep 2019
297.58M
Maximum
Dec 2023
195.63M
Average
201.56M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 398.03M |
| Rigel Pharmaceuticals Inc | 117.22M |
| Omeros Corp | 378.27M |
| Vistagen Therapeutics Inc | 131.07M |
| Karyopharm Therapeutics Inc | 240.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 130.76M |
| Shareholders Equity (Quarterly) | 166.82M |
| Debt to Equity Ratio | 0.2987 |
| Current Ratio | 4.884 |
| Net Debt Paydown Yield | -0.32% |